BOESS CARSTEN bought RCKT
June 18, 2026 · Form 4 insider transaction
BOESS CARSTEN bought 22,862 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 18 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,862
Price
$0.00
Total value
N/A
InsiderBOESS CARSTEN
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJuly 6, 2026
Shares owned after52,862
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.